Canola Oil Multi-Centre Intervention Trial (COMIT)

Human Health Benefits of Canola Products 
Start Date
End Date
Principal Investigator
Dr. Peter Jones - University of Manitoba
Dr. David Jenkins - University of Toronto, Dr. Benoît Lamarche - Laval University, Drs. Penny-Kris-Etherton and Sheila West - Penn State
MCGA Funding
Total Project Funding
External Funding Partners
SaskCanola, Alberta Canola, Canola Council of Canada

Research Objective

To examine how the consumption of different dietary oil varieties affects a broad range of metabolic responses that are important in the development of cardiovascular diseases. This study will examine the relationship between dietary oil consumption and arterial function, blood fat content, and blood markers of cardiovascular disease risk. Additionally, the efficiency of the body in converting fat from dietary oils into other specific fat compounds with know health benefits will be examined. Also, the correlation between psychosocial parameters and vascular function will be studied.

Project Description

Although consumption of omega-3 fatty acids favorably modulate circulating lipids and arterial health, there is confusion surrounding the specific health benefits of plant based alpha-linolenic acid (ALA) versus marine derived eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). This research will examine the health benefits of ALA from consumption of diets rich in canola oil, novel monounsaturated fatty acid (MUFA) and DHA enriched canola oils, and flax oil compared with a control diet representative of North American diets rich in omega-6 and saturated fats. Treatment oils will be examined for potential influence on endothelial dysfunction, inflammation, oxidation, body composition, and plasma lipoprotein characterization. Furthermore, in an effort to elucidate the genetic factors that promote ALA conversion to EPA/DHA and strengthen the role of ALA in cardiovascular health, a major objective is to correlate common genetic variants in the fatty acid desaturase 1 (FADS1) and fatty acid desaturase 2 (FADS2) gene cluster with ALA conversion to EPA/DHA and n-3 fatty acid composition of serum phospholipids in response to consumption of the treatment oils. Besides, psychosocial predictors of vascular function will be investigated.

  • Canola Growers Newsletter

    Information & events to help you maximize net income on your farm through sustainable production.



  • Canola Eat Well Newsletter

    Recipes & stories to inspire you in the kitchen & connect you to the farm with Canada’s oil, canola.